Cardiovascular Longitudinal Evaluation & Assessment of Risk (CLEAR) Study
CLEAR
1 other identifier
observational
665
1 country
4
Brief Summary
The burden of cardiovascular disease (CVD) is considerable, despite many advances in diagnosis, clinical management and drug therapy. The World Health Organization estimates 30% of global deaths are attributable to CVD and whilst mortality rates in developed countries are falling, it remains the largest single cause of death (WHO, 2007). Nineteen out of every 100 deaths in Australia are attributed to CVD, with an annual cost of $1.47 billion (AIHW, 2006). Assessing the risk of future cardiovascular events is traditionally based on a number of 'risk-factors' determined by observational clinical studies such as the Framingham cohort. Recent evidence however invalidates their use in both the highest and lowest risk groups and raises questions about applying such methods in changing risk-behaviour. A considerable number of new risk markers have surfaced in recent years (including various biomarkers, pulse wave velocity and measures of arterial function). Unfortunately their long-term predictive capacity is largely unknown, particularly when compared with existing risk factors. The aims of this study are to provide objective longitudinal data for a wide variety of risk markers both in current use and in development. Participants of current on-going clinical studies at will be approached to lengthen their observation period for the purposes of determining long-term clinical outcomes. Standard clinical observations and data obtained within the participant's enrolled studies will be collated into an electronic database. All existing and future studies must have individual approval from an appropriate ethics committee with signed consent. The baseline studies and follow-up assessments of this cohort will be correlated with cardiovascular events, hospitalizations and mortality. In addition, volunteers can be directed to appropriate clinical studies in CVD, thereby enhancing recruitment, encouraging good quality clinical studies and advancing knowledge of cardiovascular disease prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2007
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2007
CompletedFirst Posted
Study publicly available on registry
July 3, 2007
CompletedStudy Start
First participant enrolled
August 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedApril 13, 2022
April 1, 2022
14.3 years
July 2, 2007
April 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess risk factors for cardiovascular disease.
Annually
Eligibility Criteria
Participants of current and future cardiovascular trials at the Centre of Clinical Research Excellence, Department of Epidemiology \& Preventive Medicine, Monash University, Melbourne.
You may qualify if:
- Patients above 18 years of age
You may not qualify if:
- Risk assessment would constitute harm to patient
- Informed consent not obtainable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Box Hill Hospital
Box Hill, Victoria, Australia
Caulfield General Medical Centre
Caulfield, Victoria, Australia
The Northern Hospital
Epping, Victoria, Australia
Alfred Hospital
Melbourne, Victoria, 3004, Australia
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Dipak Kotecha, MBChB MRCP
Monash University
- PRINCIPAL INVESTIGATOR
John Varigos, BSc
Monash University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer
Study Record Dates
First Submitted
July 2, 2007
First Posted
July 3, 2007
Study Start
August 1, 2007
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
April 13, 2022
Record last verified: 2022-04